These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25450469)

  • 1. Acquired and genetic channelopathies: in vivo assessment of axonal excitability.
    Kuwabara S; Misawa S
    Exp Neurol; 2015 Jan; 263():368-71. PubMed ID: 25450469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonal dysfunction with voltage gated potassium channel complex antibodies.
    Park SB; Lin CS; Krishnan AV; Simon NG; Bostock H; Vincent A; Kiernan MC
    Exp Neurol; 2014 Nov; 261():337-42. PubMed ID: 24925678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
    Irani SR; Alexander S; Waters P; Kleopa KA; Pettingill P; Zuliani L; Peles E; Buckley C; Lang B; Vincent A
    Brain; 2010 Sep; 133(9):2734-48. PubMed ID: 20663977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
    Arimura K; Watanabe O
    Brain Nerve; 2010 Apr; 62(4):401-10. PubMed ID: 20420181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isaacs' syndrome as a potassium channelopathy of the nerve.
    Arimura K; Sonoda Y; Watanabe O; Nagado T; Kurono A; Tomimitsu H; Otsuka R; Kameyama M; Osame M
    Muscle Nerve Suppl; 2002; 11():S55-8. PubMed ID: 12116286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations.
    Kleopa KA; Elman LB; Lang B; Vincent A; Scherer SS
    Brain; 2006 Jun; 129(Pt 6):1570-84. PubMed ID: 16613892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of neurological channelopathies: Application of peripheral nerve excitability studies.
    Tomlinson SE; Howells J; Burke D
    Neuropharmacology; 2018 Apr; 132():98-107. PubMed ID: 28476643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impairment of peripheral nerve excitability].
    Arimura K
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1109-10. PubMed ID: 9577660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis.
    Takahashi H; Mori M; Sekiguchi Y; Misawa S; Sawai S; Hattori T; Kuwabara S
    J Neurol Sci; 2008 Dec; 275(1-2):185-7. PubMed ID: 18801496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired neuromyotonia: a new autoantibody-mediated neuronal potassium channelopathy.
    Hart IK
    Am J Med Sci; 2000 Apr; 319(4):209-16. PubMed ID: 10768605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient With voltage-gated potassium-channel (VGKC) limbic encephalitis found to have Creutzfeldt-Jakob disease (CJD) at autopsy.
    Newey CR; Appleby BS; Shook S; Sarwal A
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E05-7. PubMed ID: 24026723
    [No Abstract]   [Full Text] [Related]  

  • 12. Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.
    Tomlinson SE; Tan SV; Kullmann DM; Griggs RC; Burke D; Hanna MG; Bostock H
    Brain; 2010 Dec; 133(Pt 12):3530-40. PubMed ID: 21106501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered neuronal excitability in a Hodgkin-Huxley model incorporating channelopathies of the delayed rectifier potassium channel.
    Hafez OA; Gottschalk A
    J Comput Neurosci; 2020 Nov; 48(4):377-386. PubMed ID: 33063225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isaacs' syndrome in a patient with dermatomyositis: case report and review of the literature.
    Lertnawapan R; Kulkantrakorn K
    Int J Rheum Dis; 2017 Aug; 20(8):1039-1045. PubMed ID: 27135791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-gated potassium channel antibodies in limbic encephalitis.
    Pozo-Rosich P; Clover L; Saiz A; Vincent A; Graus F
    Ann Neurol; 2003 Oct; 54(4):530-3. PubMed ID: 14520669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-gated potassium channel antibody associated mood disorder without paraneoplastic disease.
    Kitten S; Gupta N; Bloch RM; Dunham CK
    Biol Psychiatry; 2011 Aug; 70(4):e15-7. PubMed ID: 21531392
    [No Abstract]   [Full Text] [Related]  

  • 17. Voltage-gated potassium channel antibody-associated limbic encephalitis.
    Saleem A; Sophia R
    Age Ageing; 2014 Jul; 43(4):583-5. PubMed ID: 24907351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VGKC-complex antibodies].
    Watanabe O
    Brain Nerve; 2013 Apr; 65(4):401-11. PubMed ID: 23568988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limbic encephalitis--evolving concepts].
    Serratrice G; Pellissier JF; Serratrice J; De Paula A
    Bull Acad Natl Med; 2008 Nov; 192(8):1531-41; discussion 1541-2. PubMed ID: 19445370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis.
    Iranzo A; Graus F; Clover L; Morera J; Bruna J; Vilar C; Martínez-Rodriguez JE; Vincent A; Santamaría J
    Ann Neurol; 2006 Jan; 59(1):178-81. PubMed ID: 16278841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.